血液分析装置&試薬の世界市場予測:製品・サービス別[血液アナライザー(5パート、6パート、3パート、PoC、半自動)、止血、免疫血液]、価格帯別、エンドユーザー別

◆英語タイトル:Hematology Analyzers and Reagents Market by Products & Services [Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology], Price Range (High, Low), End User (Government labs) – Global Forecast to 2025
◆商品コード:MD 2479
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年6月1日
◆ページ数:215
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

MarketsandMarkets社は血液分析装置&試薬の世界市場が2020年76億ドルから2025年106億ドルまで、年平均6.9%成長すると見込んでいます。本調査レポートでは、血液分析装置&試薬の世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、種類&サービス別(血液、止血製品、免疫血液)分析、価格帯別分析、用途別分析、使用タイプ別分析、エンドユーザー別分析、地域別分析、競争状況などを含め、提供しております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・血液分析装置&試薬の世界市場規模:種類&サービス別(血液、止血製品、免疫血液)
・血液分析装置&試薬の世界市場規模:価格帯別
・血液分析装置&試薬の世界市場規模:用途別
・血液分析装置&試薬の世界市場規模:使用タイプ別
・血液分析装置&試薬の世界市場規模:エンドユーザー別
・血液分析装置&試薬の世界市場規模:地域別
・競争状況
【レポートの概要】

“The hematology analyzers and reagents market is projected to grow at a CAGR of 6.9%.”
The global hematology analyzers and reagents market is projected to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9%. Technological advancements in hematology analyzers and reagents, the integration of flow cytometry techniques with hematology analyzers, and the increasing incidence of blood disorders are the factors expected to drive the market during the study period. However, the high cost of hematology analyzers, product recalls, and slow adoption of advanced hematology instruments in emerging countries are factors restraining the growth of this market to a certain extent.

“High-end hematology analyzers to be the fastest-growing segment during the forecast period.”
By price range, the hematology instruments market is segmented into high-end, mid-range, and low-end hematology analyzers. The lower cost of these analyzers, in comparison with high-end analyzers, is a key factor driving the adoption of these instruments. Moreover, the smaller development, validation, and launch period for mid-range hematology analyzers (approximately two years) also contribute to overall market growth. As a result, several leading players are focused on the development of innovative technologies for mid-range hematology analyzers in the market

“The Asia Pacific is expected to grow at the highest CAGR during the forecast period.”
The Asia Pacific is expected to register the highest growth rate during the forecast period due to the increasing geriatric population and the resultant growth in the incidence of thalassemia, sickle-cell anemia, and leukemia. Moreover, the improved healthcare infrastructure in countries like Japan, China, and Australia; rising number of general surgeries and organ transplantations; and the growing number of ongoing research activities are other factors also contributing to the high growth of this segment.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (45%)
• By Designation: C-level (23%), Director-level (30%), and Others (47%)
• By Region: North America (40%), Europe (30%), APAC (22%), LATAM (6%), and the MEA (2%).

The major players in the hematology analyzers and reagents market are Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland) among others.

Research Coverage
This report studies the hematology analyzers and reagents market based on products & services; the hematology products & services market is further categorized on the basis of price range, end user, and region. The report studies the factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends. The research report forecasts the revenue of market segments with respect to the five key regions and respective countries.

Reasons to Buy the Report:
From an insights perspective, this research report focuses on various levels of analysis— market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the hematology analyzers and reagents market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

【レポートの目次】

1 INTRODUCTION (Page No. – 21)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 MAJOR MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 24)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 PROCEDURE-BASED MARKET ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. – 34)

4 PREMIUM INSIGHTS (Page No. – 39)
4.1 HEMATOLOGY ANALYZERS AND REAGENTS MARKET OVERVIEW
4.2 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE
4.3 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER
4.4 GEOGRAPHIC SNAPSHOT OF THE HEMATOLOGY ANALYZERS AND REAGENTS MARKET

5 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE (Page No. – 41)
5.1 INTRODUCTION
5.2 HEMATOLOGY PRODUCTS & SERVICES
5.2.1 REAGENTS & CONSUMABLES
5.2.1.1 Hematology reagents
5.2.1.1.1 Growing preference for reagent rental business models to boost the adoption of hematology reagents
5.2.1.2 Consumables
5.2.1.2.1 Consumables are reusable, inexpensive, and required in limited quantities; supporting their adoption
5.2.1.3 Controls & calibrators
5.2.1.3.1 Controls & calibrators offer the highest quality of lab results, have long-term stability, and are convenient to use
5.2.1.4 Slide stainers/makers
5.2.1.4.1 Automated slide stainers/makers help laboratories provide cost-efficient, reliable, and uniform staining results
5.2.2 INSTRUMENTS
5.2.2.1 5-part and 6-part fully automated hematology analyzers
5.2.2.1.1 Growing preference for 5-part and 6-part hematology analyzers due to their advantages to drive market growth
5.2.2.2 3-part fully automated hematology analyzers
5.2.2.2.1 3-part analyzers offer reduced maintenance costs, making them ideal cost-effective solutions for developing countries
5.2.2.3 Point-of-care testing hematology analyzers
5.2.2.3.1 Rising inclination towards home testing of blood levels will lead to market growth
5.2.2.4 Semi-automated hematology analyzers
5.2.2.4.1 Need for manual interruption will limit the adoption of these products
5.2.3 SERVICES
5.2.3.1 High adoption of hematology diagnostic techniques will aid market growth
5.3 HEMOSTASIS PRODUCTS & SERVICES
5.3.1 REAGENTS & CONSUMABLES
5.3.1.1 Rising prevalence of coagulation disorders to support growth
5.3.2 INSTRUMENTS
5.3.2.1 Hemostasis instruments offer outstanding productivity while reducing complexities and increasing output
5.3.3 SERVICES
5.3.3.1 Advancements in hemostasis diagnostic techniques will accelerate market growth
5.4 IMMUNOHEMATOLOGY PRODUCTS & SERVICES
5.4.1 REAGENTS & CONSUMABLES
5.4.1.1 Development of novel immunohematology reagents is supporting market growth
5.4.2 INSTRUMENTS
5.4.2.1 Growing automation in immunohematology labs to boost market growth
5.4.3 SERVICES
5.4.3.1 services enable customer-focused care—a key factor driving market growth

6 HEMATOLOGY ANALYZERS MARKET, BY PRICE RANGE (Page No. – 73)
6.1 INTRODUCTION
6.2 LOW-END HEMATOLOGY ANALYZERS
6.2.1 LOWER THROUGHPUT RATES AND REDUCED ACCURACY WILL HAMPER THE MARKET GROWTH IN THIS SEGMENT
6.3 HIGH-END HEMATOLOGY ANALYZERS
6.3.1 HIGH-END ANALYZERS OFFER ADVANTAGES SUCH AS RELIABILITY, HIGH ACCURACY, FLEXIBILITY, AND EASE OF USE
6.4 MID-RANGE HEMATOLOGY ANALYZERS
6.4.1 LOWER COST OF MID-RANGE HEMATOLOGY ANALYZERS IN COMPARISON WITH HIGH-END ANALYZERS—A KEY GROWTH DRIVER

7 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION (Page No. – 78)
7.1 INTRODUCTION
7.2 HEMORRHAGIC CONDITIONS
7.2.1 INCREASE IN HEMORRHAGIC CASES TO SUPPORT THE ADOPTION OF HEMATOLOGY INSTRUMENTS
7.3 INFECTION-RELATED CONDITIONS
7.3.1 GROWING BURDEN OF INFECTIOUS DISEASES TO SUPPORT THE ADOPTION OF HEMATOLOGY INSTRUMENTS
7.4 IMMUNE SYSTEM-RELATED CONDITIONS
7.4.1 RISING USE IN POINT-OF-CARE APPLICATIONS IS LIKELY TO AID THE ADOPTION OF HEMATOLOGY ANALYZERS & REAGENTS
7.5 BLOOD CANCER
7.5.1 HEMATOLOGY ANALYZERS ARE KEY INSTRUMENTS USED FOR THE DETERMINATION OF HEMATOLOGICAL MALIGNANCIES
7.6 ANEMIA
7.6.1 GROWING INCIDENCE OF ANEMIA TO SUPPORT THE ADOPTION OF HEMATOLOGY INSTRUMENTS
7.7 OTHER APPLICATIONS

8 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE (Page No. – 85)
8.1 INTRODUCTION
8.2 STANDALONE ANALYZERS
8.2.1 INCREASED USE OF STANDALONE ANALYZERS IN HOSPITALS AND REFERENCE LABS TO DRIVE MARKET GROWTH
8.3 POINT-OF-CARE ANALYZERS
8.3.1 SMALL SAMPLE REQUIREMENT LEADING TO INCREASED PREFERENCE FOR POC ANALYZERS AMONG END USERS

9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER (Page No. – 89)
9.1 INTRODUCTION
9.2 COMMERCIAL SERVICE PROVIDERS
9.2.1 GROWING OUTSOURCING WILL INCREASE THE MARKET GROWTH IN THIS SEGMENT
9.3 HOSPITAL LABORATORIES
9.3.1 HIGH PREVALENCE OF BLOOD-RELATED DISORDERS WILL RESULT IN HIGH MARKET GROWTH
9.4 GOVERNMENT REFERENCE LABORATORIES
9.4.1 AFFORDABILITY AND PROVISION OF FREE SERVICES ARE LIKELY TO PROPEL THE GROWTH OF THIS END-USER SEGMENT
9.5 RESEARCH & ACADEMIC INSTITUTES
9.5.1 INCREASING NUMBER OF DRUG DISCOVERY AND RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH

10 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION (Page No. – 94)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Favorable research scenario will drive market growth in the US
10.2.2 CANADA
10.2.2.1 Rising demand for blood and blood components to support market growth
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Increasing number of anemic patients is a major factor driving the growth of the hematology analyzers and reagents market in Germany
10.3.2 UK
10.3.2.1 Government support to develop innovative diagnostic technologies contributing to market growth
10.3.3 FRANCE
10.3.3.1 Presence of proper protocols and guidelines in diagnostics to propel market growth in the coming years
10.3.4 ITALY
10.3.4.1 Increasing preference for hematology testing during transplantation will result in market growth
10.3.5 SPAIN
10.3.5.1 Consolidation of laboratories in Spain will drive market growth
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Government initiatives and improving healthcare infrastructure
to aid growth 124
10.4.2 JAPAN
10.4.2.1 Rising prevalence of flu in Japan in recent years is contributing to market growth
10.4.3 INDIA
10.4.3.1 High burden of chronic diseases to support market growth
10.4.4 AUSTRALIA
10.4.4.1 Rising prevalence of celiac disease to support the use of hematology analyzers and reagents
10.4.5 SOUTH KOREA
10.4.5.1 Rising healthcare spending will support market growth
10.4.6 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 BRAZIL
10.5.1.1 Investments by leading hematology analyzer and reagent manufacturers in the country to drive market growth
10.5.2 MEXICO
10.5.2.1 Rising prevalence of diabetes and cancer to support market growth in Mexico
10.5.3 REST OF LATAM
10.6 MIDDLE EAST & AFRICA
10.6.1 MEA WILL HOLD A SMALLER SHARE AND GROW AT A LOWER RATE THAN THE MAJOR REGIONAL MARKETS

11 COMPETITIVE LANDSCAPE (Page No. – 148)
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES & APPROVALS
11.3.2 PARTNERSHIPS & COLLABORATIONS
11.3.3 MERGERS & ACQUISITIONS
11.3.4 MARKET EXPANSIONS
11.4 COMPETITIVE LEADERSHIP MAPPING
11.4.1 VISIONARY LEADERS
11.4.2 INNOVATORS
11.4.3 DYNAMIC DIFFERENTIATORS
11.4.4 EMERGING COMPANIES



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[血液分析装置&試薬の世界市場予測:製品・サービス別[血液アナライザー(5パート、6パート、3パート、PoC、半自動)、止血、免疫血液]、価格帯別、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆